Ignite Creation Date:
2024-05-06 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04697576
Status:
RECRUITING
Last Update Posted:
2023-07-18
First Post:
2021-01-05
Brief Title:
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
Sponsor:
Carlo Contreras
Organization:
Ohio State University Comprehensive Cancer Center
Organization Data
Organization:
Ohio State University Comprehensive Cancer Center
Class:
OTHER
Study ID:
OSU-20221
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Carlo Contreras
Lead Sponsor Class:
OTHER
Responsible Party:
Carlo Contreras
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Ohio State University Comprehensive Cancer Center
Old Name:
None
Old Organization:
None